Look for:

Our offer for

Research Detail

2023/11/24 / Erste Group Research

US Technology sector with high earnings growth


No Rating Changes.

In Europe, around half of the companies have reported their Q3 results so far. Turnover was higher than expected for only 47% of companies. The proportion of positive sales surprises was well below the long-term average. In terms of profits, 55% of companies have reported higher profits than expected. This was a slightly higher proportion than the long-term average. 3Q earnings growth was -11.0% (y/y), excluding energy it would have been +0.5% (y/y). 3Q sales fell by -8%. Positive sales and earnings growth is not expected until 2Q 2024.

The 3Q reporting season went very well in the US. 82% of companies reported higher earnings than the consensus estimates. Earnings growth for the 3Q is +4.3% (y/y). 3Q sales growth is +2.4% (y/y). Earnings growth expected for 4Q is +2.9% (y/y) and +6.5% (y/y) for 1Q 2024.

Novo Nordisk: Very strong increase in sales and profits due to weight loss injection

Bayer: Discontinuation of a clinical trial for a potentially very important drug successor has a negative impact
Siemens: Slowdown in growth and decline in operating margin in the last quarter

PDF Download Download PDF (5.9MB)

General information

AuthorErste Group Research
Date2023/11/24
Languageen
Product nameRecommendation List
Topic in focusEquities
Economy in focusEurozone, Germany, Switzerland, United Kingdom, United States
Currency in focusBritish Pound, Euro, Swiss Franc, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities
Download

Related financial instruments

Page 1 of 5
Name  ISIN# Erste Group products
Walt DisneyUS25468710600
WalmartUS93114210390
VolkswagenDE00076640394
VisaUS92826C83940
Vinci FR00001254860
Vertex Pharmaceuticals US92532F10030
VerizonUS92343V10440
ValeBRVALEACNOR00
UnitedHealth GroupUS91324P10210
UnileverGB00B10RZP780
UniCreditIT00052393600
UBSCH02447675850
Toyota MotorJP36334000010
TotalEnergiesFR00001202710
Tokyo ElectronJP35714000050
Thermo Fisher ScientificUS88355610230
Tesla US88160R10140
TencentKYG8757216340
Taiwan SemiconductorTW00023300080
T-Mobile USUS87259010400
StarbucksUS85524410940
Southern CoUS84258710710
SiemensDE00072361010
ShellGB00B03MLX290
ServiceNowUS81762P10210



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer